Hudson Bay Capital Management »

Revance Therapeutics shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $779k 150k 5.19

More positions owned by Hudson Bay Capital Management

NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Advanced Micro Devices Put Option (AMD)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Taiwan Semiconductor Mfg Sponsored Ads Call Option (TSM)
Alphabet Cap Stk Cl C Put Option (GOOG)
Broadcom Call Option (AVGO)
New York Cmnty Bancorp Com New (NYCB)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Berkshire Hathaway Inc Del Cl B New Put Option (BRK.B)
Coinbase Global Com Cl A Put Option (COIN)
Dollar Tree Put Option (DLTR)

View all positions for Hudson Bay Capital Management

Top funds holding Revance Therapeutics

BlackRock
BlackRock
Vanguard Group
Franklin Resources
Alpine Associates Management
Magnetar Financial
Tang Capital Management
Geode Capital Management
State Street Corporation
LMR Partners
D. E. Shaw & Co
Omni Event Management
Palo Alto Investors
CNH Partners
Gabelli Funds

View all funds holding Revance Therapeutics